Biopharmaceutical Contract Manufacturing Market Forecast to 2028

Report Code : TIPRE00005512 | Region : Global | Industry : Pharmaceuticals | Published Date : 16/Feb/2022
Biopharmaceutical Contract Manufacturing Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Biologics and Biosimilar); Service (Process Development, Fill and Finish Operations, Analytical and Quality Control Studies, and Packaging), and Source (Mammalian and Microbial-Based Biologics/Non-Mammalian), and Geography

The biopharmaceutical contract manufacturing market is projected to reach US$ 27,868.50 million by 2028 from US$ 15,735.04 million in 2021; it is expected to grow at a CAGR of 8.5% from 2021 to 2028. The rising outsourcing by pharmaceutical companies is one of the most key factors driving the growth of the market. A few years ago, the contract manufacturing industry was a niche service market offering additional manufacturing capacity or specific services to pharmaceutical companies. The rise of CMOs was fueled by the increasing number of drug manufacturing failures. In the past, pharmaceutical companies had undertaken manufacturing facilities to develop innovative drugs. However, to reduce the risk of overcapacities, the demand for manufacturing outsourcing has continuously risen. Recently, Revolo Biotherapeutics entered into a partnership with contract development and manufacturing organization (CDMO)—Northway Biotech—to manufacture Revolo’s binding immuno-regulatory protein 1805. The partnership included services from cell line development to manufacturing protein with quality assurance and regulatory compliance support. Similarly, Gland Pharma has been manufacturing Remdesivir for four companies, including Mylan, since 2021. Also, the organization increased its manufacturing quotas due to high demand from the companies. In 2019, Samsung Biologics and GI Innovation signed a contract for immunochemotherapy. Under this agreement, Samsung Biologics was providing services ranging from f-cell lines development to production of Phase-I drug substances. The increasing number of contracts between biopharmaceutical companies and contract manufacturing companies shows an increasing market size for the biopharmaceutical contract manufacturing market.

The global biopharmaceutical contract management market is bifurcated on the basis of product, service, and source. Based on product, the market is segmented into biologics and biosimilar. The biologics segment would account for the largest market share during 2021–2028. Biologics are expected to see robust growth due to the various products under the segment, such as monoclonal antibodies, recombinant proteins, vaccines, and others. Biologics have an increasing demand with increasing research and developmental activities to develop new drug products for chronic indications. The COVID-19 pandemic is also expected to drive the growth of the biologics segment with the demand for vaccines for the virus rising. Also, monoclonal antibodies are needed for various chronic illnesses of metabolic, infectious, neurological, and other origins.

By service, the biopharmaceutical contract management market is segmented into process development, fill and finish operations, analytical and quality control studies, and packaging. The process development segment is expected to hold the largest share of the market during the forecast period due to highest investments in process development for production of any biopharmaceutical. The focus on pilot to commercial scale-up process development, cell line development, and other processes are expected to create growth opportunities for process development segment. The segment is further divided into downstream and upstream processing with downstream processing holding the larger share as downstream processing involves a larger amount of products being developed. The analytical and quality control studies segment is expected to have the largest growth rate.

By source, the biopharmaceutical contract management market is segmented into mammalian and microbial-based biologics/non-mammalian. The mammalian segment is expected to hold a larger share of the market as mammalian sources of cells are more commonly used in the industry and can develop a larger range of products compared to microbial-based biologics/non-mammalian sources.

The World Health Organization (WHO), Association of Clinical Research Organizations (ACRO), European Federation of Pharmaceuticals Industries Associations (EFPIA), and Pharmaceutical Research and Manufacturers of America (PhRMA) are among the primary and secondary sources referred to while preparing the report on the biopharmaceutical contract management market.

List of Companies - Biopharmaceuticals Contract Manufacturing Market

1. Lonza AG

2. Boehringer Ingelheim Biopharmaceuticals GmbH

3. Inno Bio Ventures Sdn Bhd

4. Thermo Fisher Scientific, Inc.

5. AbbVie, Inc.

6. WuXi Biologics, Inc.

7. General Electric Co.

8. Samsung Biologics Co. Ltd.

9. Merck KGaA

10. Ajinomoto Co. Inc.

TABLE OF CONTENTS

1. Introduction

1.1 Study Scope

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Global Biopharmaceutical Contract Manufacturing Market – By Product

1.3.2 Global Biopharmaceutical Contract Manufacturing Market – By Service

1.3.3 Global Biopharmaceutical Contract Manufacturing Market – By Source

1.3.4 Global Biopharmaceutical Contract Manufacturing Market – By Geography

2. Biopharmaceutical Contract Manufacturing Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Biopharmaceutical Contract Manufacturing – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 North America – PEST Analysis

4.2.2 Europe – PEST Analysis

4.2.3 Asia Pacific – PEST Analysis

4.2.4 Middle East and Africa (MEA) – PEST Analysis

4.2.5 South and Central America – PEST Analysis

4.3 Expert Opinion

5. Biopharmaceuticals Contract Manufacturing Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Rising Outsourcing by Pharmaceutical Companies

5.1.2 Increasing Demand for Biologics

5.2 Market Restraints

5.2.1 Growing Competition in Industry

5.3 Market Opportunities

5.3.1 Emerging Markets

5.4 Future Trends

5.4.1 Consolidation in Pharmaceutical CMO Industry

5.4.2 COVID-19 Pandemic

5.5 Impact Analysis

6. Biopharmaceutical Contract Manufacturing Market – Global Analysis

6.1 Global Biopharmaceutical Contract Manufacturing Market Revenue Forecast and Analysis

6.2 Global Biopharmaceutical Contract Manufacturing Market, By Geography - Forecast And Analysis

6.3 Market Positioning of Key Players

7. Biopharmaceuticals Contract Manufacturing Market Analysis – By Product

7.1 Overview

7.2 Biopharmaceuticals Contract Manufacturing Market Revenue Share, by Product (2021 and 2028)

7.3 Biologics

7.3.1 Overview

7.3.2 Biologics: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

7.3.2.1 Monoclonal Antibodies

7.3.2.1.1 Overview

7.3.2.1.2 Monoclonal Antibodies: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

7.3.2.2 Recombinant Proteins

7.3.2.2.1 Overview

7.3.2.2.2 Recombinant Proteins: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

7.3.2.3 Vaccines

7.3.2.3.1 Overview

7.3.2.3.2 Vaccines: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

7.3.2.4 Others

7.3.2.4.1 Overview

7.3.2.4.2 Others: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

7.4 Biosimilar

7.4.1 Overview

7.4.2 Biosimilar: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

8. Biopharmaceuticals Contract Manufacturing Market – By Service

8.1 Overview

8.2 Biopharmaceuticals Contract Manufacturing Market, by Service, 2021 and 2028 (%)

8.3 Process Development

8.3.1 Overview

8.3.2 Process Development: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

8.3.2.1 Downstream Processing

8.3.2.1.1 Overview

8.3.2.1.2 Downstream Processing: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

8.3.2.2 Upstream Processing

8.3.2.2.1 Overview

8.3.2.2.2 Upstream Processing: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

8.4 Fill and Finish Operations

8.4.1 Overview

8.4.2 Fill and Finish Operations: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

8.5 Analytical and Quality Control Studies

8.5.1 Overview

8.5.2 Analytical and Quality Control Studies: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

8.6 Packaging

8.6.1 Overview

8.6.2 Packaging: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

9. Biopharmaceuticals Contract Manufacturing Market – By Source

9.1 Overview

9.2 Biopharmaceuticals Contract Manufacturing Market, by Source, 2021 and 2028 (%)

9.3 Mammalian-Based Biologics

9.3.1 Overview

9.3.2 Mammalian-Based Biologics: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

9.4 Microbial/Non-Mammalian-Based Biologics

9.4.1 Overview

9.4.2 Microbial/Non-Mammalian-Based Biologics: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

10. Biopharmaceutical Contract Manufacturing Market – Geographic Analysis

10.1 North America: Biopharmaceutical Contract Manufacturing Market

10.1.1 Overview

10.1.2 North America: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

10.1.3 North America: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)

10.1.3.1 North America: Biologics Market, 2019-2028 (USD Million)

10.1.4 North America: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)

10.1.4.1 North America: Process Development Market, 2019-2028 (USD Million)

10.1.5 North America: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)

10.1.6 North America: Biopharmaceutical Contract Manufacturing Market, by Country, 2021 & 2028 (%)

10.1.6.1 US: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

10.1.6.1.1 US: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

10.1.6.1.2 US: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)

10.1.6.1.2.1 US: Biologics Market, 2019-2028 (USD Million)

10.1.6.1.3 US: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)

10.1.6.1.3.1 US: Process Development Market, 2019-2028 (USD Million)

10.1.6.1.4 US: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)

10.1.6.2 Canada: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

10.1.6.2.1 Canada: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

10.1.6.2.2 Canada: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)

10.1.6.2.2.1 Canada: Biologics Market, 2019-2028 (USD Million)

10.1.6.2.3 Canada: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)

10.1.6.2.3.1 Canada: Process Development Market, 2019-2028 (USD Million)

10.1.6.2.4 Canada: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)

10.1.6.3 Mexico: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

10.1.6.3.1 Mexico: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

10.1.6.3.2 Mexico: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)

10.1.6.3.2.1 Mexico: Biologics Market, 2019-2028 (USD Million)

10.1.6.3.3 Mexico: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)

10.1.6.3.3.1 Mexico: Process Development Market, 2019-2028 (USD Million)

10.1.6.3.4 Mexico: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)

10.2 Europe: Biopharmaceutical Contract Manufacturing Market

10.2.1 Overview

10.2.2 Europe: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2028 (USD Million)

10.2.3 Europe: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)

10.2.3.1 Europe: Biologics Market, 2019-2028 (USD Million)

10.2.4 Europe: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)

10.2.4.1 Europe: Process Development Market, 2019-2028 (USD Million)

10.2.5 Europe: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)

10.2.6 Europe: Biopharmaceutical Contract Manufacturing Market, by Country, 2021 & 2028 (%)

10.2.6.1 Germany: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

10.2.6.1.1 Germany: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

10.2.6.1.2 Germany: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)

10.2.6.1.2.1 Germany: Biologics Market, 2019-2028 (USD Million)

10.2.6.1.3 Germany: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)

10.2.6.1.3.1 Germany: Process Development Market, 2019-2028 (USD Million)

10.2.6.1.4 Germany: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)

10.2.6.2 UK: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

10.2.6.2.1 UK: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

10.2.6.2.2 UK: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)

10.2.6.2.2.1 UK: Biologics Market, 2019-2028 (USD Million)

10.2.6.2.3 UK: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)

10.2.6.2.3.1 UK: Process Development Market, 2019-2028 (USD Million)

10.2.6.2.4 UK: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)

10.2.6.3 France: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

10.2.6.3.1 France: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

10.2.6.3.2 France: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)

10.2.6.3.2.1 France: Biologics Market, 2019-2028 (USD Million)

10.2.6.3.3 France: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)

10.2.6.3.3.1 France: Process Development Market, 2019-2028 (USD Million)

10.2.6.3.4 France: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)

10.2.6.4 Spain: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

10.2.6.4.1 Spain: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

10.2.6.4.2 Spain: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)

10.2.6.4.2.1 Spain: Biologics Market, 2019-2028 (USD Million)

10.2.6.4.3 Spain: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)

10.2.6.4.3.1 Spain: Process Development Market, 2019-2028 (USD Million)

10.2.6.4.4 Spain: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)

10.2.6.5 Italy: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

10.2.6.5.1 Italy: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

10.2.6.5.2 Italy: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)

10.2.6.5.2.1 Italy: Biologics Market, 2019-2028 (USD Million)

10.2.6.5.3 Italy: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)

10.2.6.5.3.1 Italy: Process Development Market, 2019-2028 (USD Million)

10.2.6.5.4 Italy: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)

10.2.6.6 Rest of Europe: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

10.2.6.6.1 Rest of Europe: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

10.2.6.6.2 Rest of Europe: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)

10.2.6.6.2.1 Rest of Europe: Biologics Market, 2019-2028 (USD Million)

10.2.6.6.3 Rest of Europe: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)

10.2.6.6.3.1 Rest of Europe: Process Development Market, 2019-2028 (USD Million)

10.2.6.6.4 Rest of Europe: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)

10.3 Asia Pacific: Biopharmaceutical Contract Manufacturing Market

10.3.1 Overview

10.3.2 Asia Pacific: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2028 (USD Million)

10.3.3 Asia Pacific: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)

10.3.3.1 Asia Pacific: Biologics Market, 2019-2028 (USD Million)

10.3.4 Asia Pacific: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)

10.3.4.1 Asia Pacific: Process Development Market, 2019-2028 (USD Million)

10.3.5 Asia Pacific: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)

10.3.6 Asia Pacific: Biopharmaceutical Contract Manufacturing Market, by Country, 2021 & 2028 (%)

10.3.6.1 China: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

10.3.6.1.1 China: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

10.3.6.1.2 China: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)

10.3.6.1.2.1 China: Biologics Market, 2019-2028 (USD Million)

10.3.6.1.3 China: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)

10.3.6.1.3.1 China: Process Development Market, 2019-2028 (USD Million)

10.3.6.1.4 China: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)

10.3.6.2 Japan: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

10.3.6.2.1 Japan: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

10.3.6.2.2 Japan: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)

10.3.6.2.2.1 Japan: Biologics Market, 2019-2028 (USD Million)

10.3.6.2.3 Japan: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)

10.3.6.2.3.1 Japan: Process Development Market, 2019-2028 (USD Million)

10.3.6.2.4 Japan: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)

10.3.6.3 India: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

10.3.6.3.1 India: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

10.3.6.3.2 India: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)

10.3.6.3.2.1 India: Biologics Market, 2019-2028 (USD Million)

10.3.6.3.3 India: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)

10.3.6.3.3.1 India: Process Development Market, 2019-2028 (USD Million)

10.3.6.3.4 India: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)

10.3.6.4 South Korea: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

10.3.6.4.1 South Korea: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

10.3.6.4.2 South Korea: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)

10.3.6.4.2.1 South Korea: Biologics Market, 2019-2028 (USD Million)

10.3.6.4.3 South Korea: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)

10.3.6.4.3.1 South Korea: Process Development Market, 2019-2028 (USD Million)

10.3.6.4.4 South Korea: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)

10.3.6.5 Australia: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

10.3.6.5.1 Australia: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

10.3.6.5.2 Australia: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)

10.3.6.5.2.1 Australia: Biologics Market, 2019-2028 (USD Million)

10.3.6.5.3 Australia: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)

10.3.6.5.3.1 Australia: Process Development Market, 2019-2028 (USD Million)

10.3.6.5.4 Australia: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)

10.3.6.6 Rest of Asia Pacific: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

10.3.6.6.1 Rest of Asia Pacific: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

10.3.6.6.2 Rest of Asia Pacific: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)

10.3.6.6.2.1 Rest of Asia Pacific: Biologics Market, 2019-2028 (USD Million)

10.3.6.6.3 Rest of Asia Pacific: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)

10.3.6.6.3.1 Rest of Asia Pacific: Process Development Market, 2019-2028 (USD Million)

10.3.6.6.4 Rest of Asia Pacific: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)

10.4 Middle East & Africa: Biopharmaceutical Contract Manufacturing Market

10.4.1 Overview

10.4.2 Middle East & Africa: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2028 (USD Million)

10.4.3 Middle East & Africa: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)

10.4.3.1 Middle East & Africa: Biologics Market, 2019-2028 (USD Million)

10.4.4 Middle East & Africa: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)

10.4.4.1 Middle East & Africa: Process Development Market, 2019-2028 (USD Million)

10.4.5 Middle East & Africa: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)

10.4.6 Middle East & Africa: Biopharmaceutical Contract Manufacturing Market Share by Country – 2021 & 2028, (%)

10.4.6.1 Saudi Arabia: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

10.4.6.1.1 Saudi Arabia: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

10.4.6.1.2 Saudi Arabia: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)

10.4.6.1.2.1 Saudi Arabia: Biologics Market, 2019-2028 (USD Million)

10.4.6.1.3 Saudi Arabia: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)

10.4.6.1.3.1 Saudi Arabia: Process Development Market, 2019-2028 (USD Million)

10.4.6.1.4 Saudi Arabia: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)

10.4.6.2 UAE: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

10.4.6.2.1 UAE: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

10.4.6.2.2 UAE: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)

10.4.6.2.2.1 UAE: Biologics Market, 2019-2028 (USD Million)

10.4.6.2.3 UAE: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)

10.4.6.2.3.1 UAE: Process Development Market, 2019-2028 (USD Million)

10.4.6.2.4 UAE: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)

10.4.6.3 South Africa: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

10.4.6.3.1 South Africa: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

10.4.6.3.2 South Africa: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)

10.4.6.3.2.1 South Africa: Biologics Market, 2019-2028 (USD Million)

10.4.6.3.3 South Africa: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)

10.4.6.3.3.1 South Africa: Process Development Market, 2019-2028 (USD Million)

10.4.6.3.4 South Africa: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)

10.4.6.4 Rest of Middle East and Africa: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

10.4.6.4.1 Rest of Middle East and Africa: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

10.4.6.4.2 Rest of Middle East and Africa: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)

10.4.6.4.2.1 Rest of Middle East and Africa: Biologics Market, 2019-2028 (USD Million)

10.4.6.4.3 Rest of Middle East and Africa: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)

10.4.6.4.3.1 Rest of Middle East and Africa: Process Development Market, 2019-2028 (USD Million)

10.4.6.4.4 Rest of Middle East and Africa: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)

10.5 South and Central America: Biopharmaceutical Contract Manufacturing Market

10.5.1 Overview

10.5.2 South and Central America: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2028 (US$ Million)

10.5.3 South and Central America: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)

10.5.3.1 South and Central America: Biologics Market, 2019-2028 (USD Million)

10.5.4 South and Central America: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)

10.5.4.1 South and Central America: Process Development Market, 2019-2028 (USD Million)

10.5.5 South and Central America: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)

10.5.6 South and Central America: Biopharmaceutical Contract Manufacturing Market, by Country, 2021 & 2028 (%)

10.5.6.1 Brazil: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

10.5.6.1.1 Brazil: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

10.5.6.1.2 Brazil: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)

10.5.6.1.2.1 Brazil: Biologics Market, 2019-2028 (USD Million)

10.5.6.1.3 Brazil: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)

10.5.6.1.3.1 Brazil: Process Development Market, 2019-2028 (USD Million)

10.5.6.1.4 Brazil: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)

10.5.6.2 Argentina: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

10.5.6.2.1 Argentina: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

10.5.6.2.2 Argentina: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)

10.5.6.2.2.1 Argentina: Biologics Market, 2019-2028 (USD Million)

10.5.6.2.3 Argentina: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)

10.5.6.2.3.1 Argentina: Process Development Market, 2019-2028 (USD Million)

10.5.6.2.4 Argentina: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)

10.5.6.3 Rest of South and Central America: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

10.5.6.3.1 Rest of South and Central America: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

10.5.6.3.2 Rest of South and Central America: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)

10.5.6.3.2.1 Rest of South and Central America: Biologics Market, 2019-2028 (USD Million)

10.5.6.3.3 Rest of South and Central America: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)

10.5.6.3.3.1 Rest of South and Central America: Process Development Market, 2019-2028 (USD Million)

10.5.6.3.4 Rest of South and Central America: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)

11. Impact of COVID-19 Pandemic on Biopharmaceutical Contract Manufacturing Market

11.1 North America: Impact Assessment of COVID-19 Pandemic

11.2 Europe: Impact Assessment of COVID-19 Pandemic

11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic

11.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic

11.5 South and Central America: Impact Assessment of COVID-19 Pandemic

12. Biopharmaceutical Contract Manufacturing Market – Industry Landscape

12.1 Overview

12.2 Growth Strategies Done by the Companies in the Market, (%)

12.3 Organic Developments

12.3.1 Overview

12.4 Inorganic Developments

12.4.1 Overview

13. Company Profiles

13.1 Boehringer Ingelheim International GmbH

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 THERMO FISHER SCIENTIFIC INC.

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 General Electric Company

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 MERCK KGAA

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 Lonza

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 Samsung Biologics

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 AbbVie Inc.

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 WUXI BIOLOGICS

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

13.9 Ajinomoto Co. Inc.

13.9.1 Key Facts

13.9.2 Business Description

13.9.3 Products and Services

13.9.4 Financial Overview

13.9.5 SWOT Analysis

13.9.6 Key Developments

13.10 Inno Bio Ventures Sdn Bhd

13.10.1 Key Facts

13.10.2 Business Description

13.10.3 Products and Services

13.10.4 Financial Overview

13.10.5 SWOT Analysis

13.10.6 Key Developments

14. Appendix

14.1 About The Insight Partners

14.2 Glossary of Terms

LIST OF TABLES.

Table 1. North America Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)

Table 2. North America Biologics Market – Revenue and Forecast to 2028 (USD Million)

Table 3. North America Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)

Table 4. North America Process Development Market – Revenue and Forecast to 2028 (USD Million)

Table 5. North America Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)

Table 6. US Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)

Table 7. US Biologics Market – Revenue and Forecast to 2028 (USD Million)

Table 8. US Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)

Table 9. US Process Development Market – Revenue and Forecast to 2028 (USD Million)

Table 10. US Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)

Table 11. Canada Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)

Table 12. Canada Biologics Market – Revenue and Forecast to 2028 (USD Million)

Table 13. Canada Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)

Table 14. Canada Process Development Market – Revenue and Forecast to 2028 (USD Million)

Table 15. Canada Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)

Table 16. Mexico Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)

Table 17. Mexico Biologics Market – Revenue and Forecast to 2028 (USD Million)

Table 18. Mexico Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)

Table 19. Mexico Process Development Market – Revenue and Forecast to 2028 (USD Million)

Table 20. Mexico Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)

Table 21. Europe Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)

Table 22. Europe Biologics Market – Revenue and Forecast to 2028 (USD Million)

Table 23. Europe Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)

Table 24. Europe Process Development Market – Revenue and Forecast to 2028 (USD Million)

Table 25. Europe Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)

Table 26. Germany Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)

Table 27. Germany Biologics Market – Revenue and Forecast to 2028 (USD Million)

Table 28. Germany Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)

Table 29. Germany Process Development Market – Revenue and Forecast to 2028 (USD Million)

Table 30. Germany Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)

Table 31. UK Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)

Table 32. UK Biologics Market – Revenue and Forecast to 2028 (USD Million)

Table 33. UK Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)

Table 34. UK Process Development Market – Revenue and Forecast to 2028 (USD Million)

Table 35. UK Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)

Table 36. France Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)

Table 37. France Biologics Market – Revenue and Forecast to 2028 (USD Million)

Table 38. France Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)

Table 39. France Process Development Market – Revenue and Forecast to 2028 (USD Million)

Table 40. France Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)

Table 41. Spain Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)

Table 42. Spain Biologics Market – Revenue and Forecast to 2028 (USD Million)

Table 43. Spain Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)

Table 44. Spain Process Development Market – Revenue and Forecast to 2028 (USD Million)

Table 45. Spain Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)

Table 46. Italy Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)

Table 47. Italy Biologics Market – Revenue and Forecast to 2028 (USD Million)

Table 48. Italy Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)

Table 49. Italy Process Development Market – Revenue and Forecast to 2028 (USD Million)

Table 50. Italy Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)

Table 51. Rest of Europe Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)

Table 52. Rest of Europe Biologics Market – Revenue and Forecast to 2028 (USD Million)

Table 53. Rest of Europe Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)

Table 54. Rest of Europe Process Development Market – Revenue and Forecast to 2028 (USD Million)

Table 55. Rest of Europe Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)

Table 56. Asia Pacific Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)

Table 57. Asia Pacific Biologics Market – Revenue and Forecast to 2028 (USD Million)

Table 58. Asia Pacific Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)

Table 59. Asia Pacific Process Development Market – Revenue and Forecast to 2028 (USD Million)

Table 60. Asia Pacific Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)

Table 61. China Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)

Table 62. China Biologics Market – Revenue and Forecast to 2028 (USD Million)

Table 63. China Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)

Table 64. China Process Development Market – Revenue and Forecast to 2028 (USD Million)

Table 65. China Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)

Table 66. Japan Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)

Table 67. Japan Biologics Market – Revenue and Forecast to 2028 (USD Million)

Table 68. Japan Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)

Table 69. Japan Process Development Market – Revenue and Forecast to 2028 (USD Million)

Table 70. Japan Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)

Table 71. India: R&D spending of Pharmaceutical companies (2010 & 2017)

Table 72. India Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)

Table 73. India Biologics Market – Revenue and Forecast to 2028 (USD Million)

Table 74. India Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)

Table 75. India Process Development Market – Revenue and Forecast to 2028 (USD Million)

Table 76. India Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)

Table 77. South Korea Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)

Table 78. South Korea Biologics Market – Revenue and Forecast to 2028 (USD Million)

Table 79. South Korea Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)

Table 80. South Korea Process Development Market – Revenue and Forecast to 2028 (USD Million)

Table 81. South Korea Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)

Table 82. Australia Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)

Table 83. Australia Biologics Market – Revenue and Forecast to 2028 (USD Million)

Table 84. Australia Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)

Table 85. Australia Process Development Market – Revenue and Forecast to 2028 (USD Million)

Table 86. Australia Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)

Table 87. Rest of Asia Pacific Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)

Table 88. Rest of Asia Pacific Biologics Market – Revenue and Forecast to 2028 (USD Million)

Table 89. Rest of Asia Pacific Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)

Table 90. Rest of Asia Pacific Process Development Market – Revenue and Forecast to 2028 (USD Million)

Table 91. Rest of Asia Pacific Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)

Table 92. Middle East & Africa Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)

Table 93. Middle East & Africa Biologics Market – Revenue and Forecast to 2028 (USD Million)

Table 94. Middle East & Africa Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)

Table 95. Middle East & Africa Process Development Market – Revenue and Forecast to 2028 (USD Million)

Table 96. Middle East & Africa Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)

Table 97. Saudi Arabia Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)

Table 98. Saudi Arabia Biologics Market – Revenue and Forecast to 2028 (USD Million)

Table 99. Saudi Arabia Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)

Table 100. Saudi Arabia Process Development Market – Revenue and Forecast to 2028 (USD Million)

Table 101. Saudi Arabia Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)

Table 102. UAE Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)

Table 103. UAE Biologics Market – Revenue and Forecast to 2028 (USD Million)

Table 104. UAE Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)

Table 105. UAE Process Development Market – Revenue and Forecast to 2028 (USD Million)

Table 106. UAE Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)

Table 107. South Africa Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)

Table 108. South Africa Biologics Market – Revenue and Forecast to 2028 (USD Million)

Table 109. South Africa Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)

Table 110. South Africa Process Development Market – Revenue and Forecast to 2028 (USD Million)

Table 111. South Africa Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)

Table 112. Rest of Middle East and Africa Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)

Table 113. Rest of Middle East and Africa Biologics Market – Revenue and Forecast to 2028 (USD Million)

Table 114. Rest of Middle East and Africa Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)

Table 115. Rest of Middle East and Africa Process Development Market – Revenue and Forecast to 2028 (USD Million)

Table 116. Rest of Middle East and Africa Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)

Table 117. South and Central America Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)

Table 118. South and Central America Biologics Market – Revenue and Forecast to 2028 (USD Million)

Table 119. South and Central America Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)

Table 120. South and Central America Process Development Market – Revenue and Forecast to 2028 (USD Million)

Table 121. South and Central America Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)

Table 122. Brazil Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)

Table 123. Brazil Biologics Market – Revenue and Forecast to 2028 (USD Million)

Table 124. Brazil Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)

Table 125. Brazil Process Development Market – Revenue and Forecast to 2028 (USD Million)

Table 126. Brazil Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)

Table 127. Argentina Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)

Table 128. Argentina Biologics Market – Revenue and Forecast to 2028 (USD Million)

Table 129. Argentina Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)

Table 130. Argentina Process Development Market – Revenue and Forecast to 2028 (USD Million)

Table 131. Argentina Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)

Table 132. Rest of South and Central America Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)

Table 133. Rest of South and Central America Biologics Market – Revenue and Forecast to 2028 (USD Million)

Table 134. Rest of South and Central America Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)

Table 135. Rest of South and Central America Process Development Market – Revenue and Forecast to 2028 (USD Million)

Table 136. Rest of South and Central America Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)

Table 137. Organic Developments Done By Companies

Table 138. Inorganic Developments Done By Companies

Table 139. Glossary of Terms, Biopharmaceutical Contract Manufacturing Market

List of Companies - Biopharmaceuticals Contract Manufacturing Market

1. Lonza AG

2. Boehringer Ingelheim Biopharmaceuticals GmbH

3. Inno Bio Ventures Sdn Bhd

4. Thermo Fisher Scientific, Inc.

5. AbbVie, Inc.

6. WuXi Biologics, Inc.

7. General Electric Co.

8. Samsung Biologics Co. Ltd.

9. Merck KGaA

10. Ajinomoto Co. Inc.

Reason To Buy

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the biopharmaceuticals contract manufacturing market.

• Highlights key business priorities in order to assist companies to realign their business strategies.

• The key findings and recommendations highlight crucial progressive industry trends in the global biopharmaceuticals contract manufacturing market, thereby allowing players across the value chain to develop effective long-term strategies.

• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

• Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

• Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.

AVAILABLE CUSTOMIZATION RESEARCH METHODOLOGY REQUEST FOR TOC FREE SAMPLE REPORT
CHOOSE LICENCE TYPE
(Biopharmaceutical Contract Manufacturing Market Forecast to 2028 )
  • Single User Price $4,550$3,640
  • Site Price $6,550$5,240
  • Enterprise Price $8,550$6,840
Buy Now Add to Cart
REQUEST FOR TOC
SPEAK TO ANALYST
FREE SAMPLE
REPORT
INQUIRE BEFORE
BUYING
TOP
Quick Enquiry